Challenges in the Management of Esophagogastric Varices and Variceal Hemorrhage in Cirrhosis – A Narrative Review - 24/02/24
, Juan Carlos Garcia-Pagan, MD, PhD c, 1, Virginia Hernández-Gea, MD, PhD cAbstract |
Over the past decade, significant advancements in pharmacological, endoscopic, and radiographic treatments have emerged in the management of patients with cirrhosis and esophagogastric varices or variceal hemorrhage. These advances have been in several areas, including the role of screening and primary prophylaxis (preventing an initial variceal bleed), evaluation and management of acute esophagogastric variceal hemorrhage, and in preventing variceal rebleeding. Therefore, we believe there is a need for an updated, evidence-based “narrative review” on this important clinical topic that will be relevant for internists, hospitalists, intensive care unit physicians, and those in training. We believe the guidance presented in this narrative review will enhance daily medical practice of health care professionals and has the potential to improve quality of care for these complex patients.
El texto completo de este artículo está disponible en PDF.Esquema
| Funding: None. |
|
| Conflicts of Interest: IG – Astra-Zeneca, Boston Scientific, Medtronic, Motus GI, Check Cap; JCG-P – Unrestricted grant from GORE and Mallinkrodt; Speaker fee from Cook Medical; VHG – GORE, Cook Medical. |
|
| Authorship: IG – Review conceptualization, Literature identification/analysis, Writing – original draft and review/editing; JCG-P – Review conceptualization, Literature identification/analysis, Writing – original draft and review/editing; VHG – Review conceptualization, Literature identification/analysis, Writing – original draft and review/editing; all 3 authors contributed equally. |
Vol 137 - N° 3
P. 210-217 - mars 2024 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
